Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Investigation
- Vol. 26 (10), 1024-1031
- https://doi.org/10.1080/07357900802098165
Abstract
Tumor-infiltrating leukocytes and other immunohistochemical parameters were evaluated in pretherapeutic biopsies and resection specimens in 73 patients undergoing neoadjuvant chemotherapy with doxorubicin and paclitaxel. Ten patients with pathological complete response had significantly higher p53 expression, CD3+ lymphocyte and CD83+ cell counts, and lower progesterone receptor expression. In the remaining 63 patients, a significant decrease in the percentage of Ki-67, vascular endothelial growth factor expression, CD68+ monocytes, and increased CD31+, CD34+, and SMA+ stromal vessels, maximal CD3+ and CD56+ lymphocyte, maximal and mean CD83+ cell, maximal CD1a+, and maximal and mean S100+ cell counts were observed after neoadjuvant chemotherapy.Keywords
This publication has 38 references indexed in Scilit:
- Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicatorsSurgery, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerBritish Journal of Cancer, 2002
- Does Famotidine Enhance Tumor Infiltrating Lymphocytes in Breast Cancer?Acta Oncologica, 2002
- Concurrent immunohistochemical staining of tumor-infiltrating lymphocytes and carcinoma-associated T (Thomsen-Friedenreich)/Tn antigens in human breast carcinoma.Journal of Histochemistry & Cytochemistry, 1996
- Chemotherapy‐induced differential changes in lymphocyte subsets and natural‐killer‐cell function in patients with advanced breast cancerInternational Journal of Cancer, 1993
- Inflammatory Breast CancerAmerican Journal of Clinical Oncology, 1993
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991